What is the market cap difference between ABBV and BMY?

ABBV has a market cap of $410.8B and BMY has a market cap of $123.7B. ABBV has a 3.3x larger market capitalization than BMY

ABBV vs BMY Stock Comparison

Compare AbbVie Inc. (ABBV) and Bristol-Myers Squibb Company (BMY) side by side. View price, valuation, dividends, and financial metrics.

AbbVie Inc.

$232.35-1.63%

Healthcare / Drug Manufacturers - General · $410.8B market cap

Bristol-Myers Squibb Company

$60.74-2.55%

Healthcare / Drug Manufacturers - General · $123.7B market cap

Both ABBV and BMY operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

ABBV has a 3.3x larger market capitalization than BMY.

BMY trades at a lower P/E ratio (17.6x) compared to ABBV (98.0x), suggesting BMY may be more attractively valued relative to its earnings.

BMY offers a higher dividend yield (4.15%) vs ABBV (2.98%), making it more attractive for income investors.

Looking at profitability, ABBV has a profit margin of 684.4% while BMY's is 1463.7%. BMY converts more of its revenue into profit.

In terms of growth, ABBV has revenue growth of 10.0% versus 1.3% for BMY. ABBV is growing its top line faster.

Which is a better investment, ABBV or BMY?: Both stocks have different strengths. AbbVie Inc. (ABBV) trades at $232.35 with a $410.8B market cap, while Bristol-Myers Squibb Company (BMY) trades at $60.74 with a $123.7B market cap. BMY trades at a lower P/E ratio (17.6x) compared to ABBV (98.0x), suggesting BMY may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are ABBV and BMY in the same sector?: Both ABBV and BMY operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do ABBV and BMY pay dividends?: BMY offers a higher dividend yield (4.15%) vs ABBV (2.98%), making it more attractive for income investors.